The Department of Health (DOH) will look into the reason why the government bought the now-controversial vaccine, Dengvaxia, for P1,000 per dose instead of P600, Health Secretary Francisco III said on Wednesday.Read more
As the Senate investigation into the P3.5 billion anti-dengue immunization program started on Monday, lawmakers appealed for answers and solutions in the midst of the vaccine fiasco that might have endangered the lives of more than 800,000 children.
The post Senators seek for answers, solutions amid anti-dengue vaccine mess appeared first on Inquirer News.Read more
The Commission on Audit (COA) has ordered officials of the Department of Health (DOH) and higher-ranking employees to return P14.04 million in excessive hazard pay.
The post COA orders DOH officials to return P14-M excess hazard pay appeared first on Inquirer News.Read more
Some Quezon City policemen and civilian personnel who availed themselves of the free dengue shots in September have expressed concern over their health after the manufacturer, Sanofi Pasteur, said it could lead to more serious diseases.Read more
Vice President Leni Robredo on Sunday called on the government to look into the effects of a wrongly administered dengue vaccine on the health of hundreds of thousands of schoolchildren in the country and ensure that those who bungled the immunization program would be held liable.Read more
Malacañang has assured the public that those responsible in the P3.5-billion dengue vaccine fiasco it called a “shameless public health scam” will be held accountable.Read more
The Department of Health said yesterday that it had suspended use of a landmark vaccine for the potentially deadly dengue virus after its manufacturer warned it could worsen the disease in some cases.Read more
In December 2015, Dengvaxia, the world’s first vaccine against dengue virus developed by French pharmaceutical company Sanofi Pasteur, was licensed and approved for use in the Philippines by the Food and Drug Administration (FDA).Read more
The Department of Health (DOH) has suspended a massive dengue immunization program and on Friday ordered the close observation of those who had received the world’s first antidengue vaccine after its manufacturer admitted it could worsen the disease in some cases.
The post Citing risks, DOH stops P3.5-B dengue vaccine drive appeared first on Inquirer News.Read more